DUBLIN--(BUSINESS WIRE)--The "Chitin and Chitosan Derivatives - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024.
Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Chitin and Chitosan Derivatives in Metric Tons.
The market for Chitin is analyzed by the following Derivatives:
- Glucosamine
- Chitosan
- others
The market for Chitosan is analyzed by the following End-Use Applications:
- Water Treatment
- Cosmetics & Toiletries
- Food & Beverages
- Healthcare/Medical
- Agrochemicals
- Biotechnology
- others
The report profiles 50 companies including many key and niche players such as:
- Advanced Biopolymers AS (Norway)
- FMC Corp. (US)
- Golden-Shell Pharmaceutical Co., Ltd. (China)
- G.T.C. Bio Corporation (China)
- KYTOSAN USA, LLC (US)
- Kitozyme (Belgium)
- Heppe Medical Chitosan GmbH (Germany)
- Kunpoong Bio Co., Ltd. (South Korea)
- Meron Biopolymers (India)
- Primex Ehf (Iceland)
- Zhejiang Candorly Pharmaceutical Co., Ltd. (China)
Key Topics Covered:
1. Industry Overview
2. Market Dynamics
3. Product Overview
4. End-Use Applications: A Broad Spectrum
5. Recent Industry Activity
6. Focus on Select Players
7. Global Market Perspective
Total Companies Profiled: 50 (including Divisions/Subsidiaries - 51)
The United States (8)
Japan (3)
Europe (11)
- France (2)
- Germany (2)
- The United Kingdom (1)
- Rest of Europe (6)
Asia-Pacific (Excluding Japan) (27)
Middle East (1)
Latin America (1)
For more information about this report visit https://www.researchandmarkets.com/research/vwfnch/2018_global?w=4